| abstract |
The present invention relates to a compound that is useful as an active ingredient of a pharmaceutical composition, in particular a pharmaceutical composition for preventing or treating conditions associated with and / or mediated by β-secretase activity, hydrolysis of the β-secretase cleavage site of the amyloid precursor protein and / or accumulation β-amyloid protein, including pharmaceutical compositions for prophylaxis or treatment, including but not limited to glaucoma, MCI (mild cognitive impairment) or Alzheimer's disease, mainly m, the Alzheimer's disease. |